TCL Archive ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer October 9, 2009
TCL Archive New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White November 30, 1984
TCL Archive Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach. July 9, 2004